Sage Therapeutics increases proposed IPO deal size

By
A A A

Sage Therapeutics, which is developing treatments for life-threatening epileptic seizures, raised the proposed deal size for its upcoming IPO on Thursday. The Cambridge, MA-based company now plans to raise $88 million by offering 5 million shares at a price range of $17 to $18. The company had previously filed to offer 4 million shares at a range of $14 to $16.

At the midpoint of the revised range, Sage Therapeutics will raise 46% greater proceeds than previously anticipated at a market cap of $463 million, up 21% from its prior $382 million market cap.

Sage Therapeutics, which was founded in 2010, plans to list on the NASDAQ under the symbol SAGE. J.P. Morgan and Goldman Sachs are the joint bookrunners on the deal. It is expected to price tonight, July 17, 2014.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: SAGE

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

91,252,153
  • $13.78 ▼ 4.31%
68,133,496
  • $12.93 ▲ 6.77%
57,268,074
  • $46.13 ▲ 2.47%
43,432,023
  • $105.22 ▲ 0.37%
40,880,685
  • $13.46 ▲ 8.90%
40,712,405
  • $98.62 ▲ 0.82%
39,776,976
  • $16.72 ▲ 0.72%
34,688,871
  • $11.16 ▲ 3.05%
As of 10/24/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com